Overview

VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)

Status:
Suspended
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
We propose a 3-arm RCT to determine the efficacy of hydroxychloroquine or azithromycin in treating mild to moderate COVID-19 among Veterans in the outpatient setting.
Phase:
Phase 3
Details
Lead Sponsor:
Salomeh Keyhani MD
Collaborator:
San Francisco VA Health Care System
Treatments:
Azithromycin
Hydroxychloroquine